Headline News about Eli Lilly![]() ![]() ![]() ![]() Via Benzinga
![]() ![]()
Market Whales and Their Recent Bets on LLY Options
June 06, 2024
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]()
ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential
June 07, 2024
Via Benzinga
Topics
ETFs
![]() ![]() ![]() ![]()
Eli Lilly's Alzheimer's Drug, Donanemab Faces FDA's Adcomm Vote Next Week On Data, Risk Profile
June 06, 2024
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|